Correlation Between Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS INC, you can compare the effects of market volatilities on Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of OUTLOOK THERAPEUTICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS.

Diversification Opportunities for Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS

-0.91
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Fennec and OUTLOOK is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OUTLOOK THERAPEUTICS INC and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with OUTLOOK THERAPEUTICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OUTLOOK THERAPEUTICS INC has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS

Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 0.43 times more return on investment than OUTLOOK THERAPEUTICS. However, Fennec Pharmaceuticals is 2.34 times less risky than OUTLOOK THERAPEUTICS. It trades about 0.1 of its potential returns per unit of risk. OUTLOOK THERAPEUTICS INC is currently generating about -0.05 per unit of risk. If you would invest  446.00  in Fennec Pharmaceuticals on October 23, 2024 and sell it today you would earn a total of  108.00  from holding Fennec Pharmaceuticals or generate 24.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Fennec Pharmaceuticals  vs.  OUTLOOK THERAPEUTICS INC

 Performance 
       Timeline  
Fennec Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.
OUTLOOK THERAPEUTICS INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OUTLOOK THERAPEUTICS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS

The main advantage of trading using opposite Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, OUTLOOK THERAPEUTICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OUTLOOK THERAPEUTICS will offset losses from the drop in OUTLOOK THERAPEUTICS's long position.
The idea behind Fennec Pharmaceuticals and OUTLOOK THERAPEUTICS INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope